Legal And Ethical Considerations In Marketing Product 935838

Question

Legal And Ethical Considerations In Marketing Product S

Research three to five (3-5) ethical issues relating to marketing and advertising, intellectual property, and regulation of product safety and examine whether PharmaCARE violated any of the issues in question. Argue for or against Direct-to-Consumer (DTC) marketing by drug companies. Provide support for your response.

Determine the parties responsible for regulating compounding pharmacies under the current regulatory scheme, the actions that either these parties or the FDA could / should have taken in this scenario, and whether PharmaCARE could face legal exposure surrounding its practices. Support your response.

Analyze the manner in which PharmaCARE used U.S. law to protect its own intellectual property and if John has any claim to being the true “inventor” of AD23. Suggest at least three (3) ways the company could compensate John for the use of his intellectual property.

Summarize at least one (1) current example (within the past two [2] years) of intellectual property theft, and examine the effect on that company’s brand.

Analyze the potential issue surrounding the death of John’s wife and other potential litigants against PharmaCARE as a result of AD23. Specify both the major arguments that John can make to claim that he is a whistleblower and the type of protections that he should be afforded. Justify your response.

References

Smith, J. A., & Johnson, R. L. (2023). Ethical considerations in pharmaceutical marketing: A recent case review. Journal of Business Ethics, 180(2), 345-359.

Doe, M., & Lee, S. K. (2022). Intellectual property and innovation protection in the pharmaceutical industry. Intellectual Property Law Journal, 34(4), 201-220.

Center for Drug Evaluation and Research. (2023). Regulation of compounded drugs. U.S. Food and Drug Administration. https://www.fda.gov

Williams, T. (2022). Direct-to-consumer pharmaceutical advertising: Ethical dilemmas and policy implications. Healthcare Policy, 18(1), 44-56.

Miller, A., & Chen, Y. (2023). Recent cases of intellectual property theft in healthcare. Harvard Business Review, 101(3), 122-125.

Dr. Jack HW Helper · Accepted Answer

Legal And Ethical Considerations In Marketing Product S

Research three to five (3-5) ethical issues relating to marketing and advertising, intellectual property, and regulation of product safety and examine whether PharmaCARE violated any of the issues in question. Argue for or against Direct-to-Consumer (DTC) marketing by drug companies. Provide support for your response.

Determine the parties responsible for regulating compounding pharmacies under the current regulatory scheme, the actions that either these parties or the FDA could / should have taken in this scenario, and whether PharmaCARE could face legal exposure surrounding its practices. Support your response.

Analyze the manner in which PharmaCARE used U.S. law to protect its own intellectual property and if John has any claim to being the true “inventor” of AD23. Suggest at least three (3) ways the company could compensate John for the use of his intellectual property.

Summarize at least one (1) current example (within the past two [2] years) of intellectual property theft, and examine the effect on that company’s brand.

Analyze the potential issue surrounding the death of John’s wife and other potential litigants against PharmaCARE as a result of AD23. Specify both the major arguments that John can make to claim that he is a whistleblower and the type of protections that he should be afforded. Justify your response.

References

Smith, J. A., & Johnson, R. L. (2023). Ethical considerations in pharmaceutical marketing: A recent case review. Journal of Business Ethics, 180(2), 345-359.

Doe, M., & Lee, S. K. (2022). Intellectual property and innovation protection in the pharmaceutical industry. Intellectual Property Law Journal, 34(4), 201-220.

Center for Drug Evaluation and Research. (2023). Regulation of compounded drugs. U.S. Food and Drug Administration. https://www.fda.gov

Williams, T. (2022). Direct-to-consumer pharmaceutical advertising: Ethical dilemmas and policy implications. Healthcare Policy, 18(1), 44-56.

Miller, A., & Chen, Y. (2023). Recent cases of intellectual property theft in healthcare. Harvard Business Review, 101(3), 122-125.

Legal And Ethical Considerations In Marketing Product S

Analyze the manner in which PharmaCARE used U.S. law to protect its own intellectual property and if John has any claim to being the true “inventor” of AD23. Suggest at least three (3) ways the company could compensate John for the use of his intellectual property.

Summarize at least one (1) current example (within the past two [2] years) of intellectual property theft, and examine the effect on that company’s brand.

References

Related Assignments